Darotropium bromide
Alternative Names: 233705; GSK 233705Latest Information Update: 05 Nov 2023
At a glance
- Originator GlaxoSmithKline
- Class Bronchodilators; Small molecules
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease